The figure shows a mixed-effects meta-regression of efficacy as
a function of treatment delay, for all studies that specify the time between symptom onset and treatment across all 221 treatments we cover.
Efficacy declines rapidly with treatment delay (p < 0.0000001).
As with other viral infections, early treatment is critical for COVID-19.
